The study shows the heart team is “working,” say some, but one surgeon says TAVI use is still worryingly high in this group.

The analysis, based on Medicare data, also showed women have higher risks of complications and early mortality than men.

With one positive and one neutral trial, the jury is still out on whether intra-arterial hypothermia boosts functional outcomes.

South London data show stroke became more common in Black African and Caribbean people but stayed steady in white peers.

The blood or saliva test results can be used as a “risk enhancer” for patients who fall in treatment gray zones, study author ...

Rick Nishimura and Michael Mack outline the evolving role of surgery in the treatment of severe tricuspid regurgitation ...

May 6, 2026 | Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke. Receive the the latest news, research, ...

The use of aficamten (Myqorzo; Cytokinetics), a selective cardiac myosin inhibitor, in patients with nonobstructive hypertrophic cardiomyopathy (HCM) improves physical limitations, symptoms, and peak ...

Considering some unique trial features, the results should be seen “more as hypothesis-generating than practice-changing.” ...

“Defibrillation testing can be safely omitted after S-ICD implantation when guided by the PRAETORIAN score,” Knops concluded, ...